Literature DB >> 20938437

The ShangRing device for simplified adult circumcision.

Puneet Masson1, Philip S Li, Mark A Barone, Marc Goldstein.   

Abstract

Adult male circumcision reduces HIV transmission through vaginal intercourse and is being promoted in areas where HIV is widespread. Conventional surgical circumcision involves suturing and thus requires practitioners with surgical skills. It is also associated with complications, including bleeding and infection, especially in resource-poor settings. The ShangRing (Wuhu Snnda Medical Treatment Appliance Technology Co. Ltd, Wuhu City, China) has been used to perform thousands of circumcisions in adult men, principally in China. It consists of two concentric plastic rings that sandwich the foreskin of the penis, allowing circumcision without stitches or notable bleeding. As well as substantially reduced operative times, ShangRing adult male circumcision is associated with a low complication rate, and the technique can easily be taught to both physician and nonphysician personnel. The simple technique and successful outcomes associated with the ShangRing procedure mean that the device could enable standardization of adult male circumcision, helping HIV prevention efforts throughout the developing world.

Entities:  

Mesh:

Year:  2010        PMID: 20938437     DOI: 10.1038/nrurol.2010.167

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  19 in total

Review 1.  Circumcision: a consideration of some of the controversy.

Authors:  Doreen Anne Crawford
Journal:  J Child Health Care       Date:  2002-12       Impact factor: 1.979

2.  High rate of adverse events following circumcision of young male adults with the Tara KLamp technique: a randomised trial in South Africa.

Authors:  Emmanuel Lagarde; Dirk Taljaard; Adrian Puren; Bertran Auvert
Journal:  S Afr Med J       Date:  2009-03

3.  Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.

Authors:  Ronald H Gray; Godfrey Kigozi; David Serwadda; Frederick Makumbi; Stephen Watya; Fred Nalugoda; Noah Kiwanuka; Lawrence H Moulton; Mohammad A Chaudhary; Michael Z Chen; Nelson K Sewankambo; Fred Wabwire-Mangen; Melanie C Bacon; Carolyn F M Williams; Pius Opendi; Steven J Reynolds; Oliver Laeyendecker; Thomas C Quinn; Maria J Wawer
Journal:  Lancet       Date:  2007-02-24       Impact factor: 79.321

4.  Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.

Authors:  Robert C Bailey; Stephen Moses; Corette B Parker; Kawango Agot; Ian Maclean; John N Krieger; Carolyn F M Williams; Richard T Campbell; Jeckoniah O Ndinya-Achola
Journal:  Lancet       Date:  2007-02-24       Impact factor: 79.321

5.  Clinical application of a new device for minimally invasive circumcision.

Authors:  Yi-Feng Peng; Yue Cheng; Guo-Yao Wang; Suo-Qun Wang; Chao Jia; Ben-Hai Yang; Ru Zhu; Shu-Chuan Jian; Qing-Wen Li; Da-Wei Geng
Journal:  Asian J Androl       Date:  2008-05       Impact factor: 3.285

6.  Male circumcision for HIV prevention: a prospective study of complications in clinical and traditional settings in Bungoma, Kenya.

Authors:  Robert C Bailey; Omar Egesah; Stephanie Rosenberg
Journal:  Bull World Health Organ       Date:  2008-09       Impact factor: 9.408

7.  Male circumcision for the prevention of HSV-2 and HPV infections and syphilis.

Authors:  Aaron A R Tobian; David Serwadda; Thomas C Quinn; Godfrey Kigozi; Patti E Gravitt; Oliver Laeyendecker; Blake Charvat; Victor Ssempijja; Melissa Riedesel; Amy E Oliver; Rebecca G Nowak; Lawrence H Moulton; Michael Z Chen; Steven J Reynolds; Maria J Wawer; Ronald H Gray
Journal:  N Engl J Med       Date:  2009-03-26       Impact factor: 91.245

Review 8.  Complications of circumcision.

Authors:  N Williams; L Kapila
Journal:  Br J Surg       Date:  1993-10       Impact factor: 6.939

9.  Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.

Authors:  Bertran Auvert; Dirk Taljaard; Emmanuel Lagarde; Joëlle Sobngwi-Tambekou; Rémi Sitta; Adrian Puren
Journal:  PLoS Med       Date:  2005-10-25       Impact factor: 11.069

Review 10.  Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making?

Authors: 
Journal:  PLoS Med       Date:  2009-09-08       Impact factor: 11.069

View more
  10 in total

1.  The acceptability and safety of the Shang Ring for adult male circumcision in Rakai, Uganda.

Authors:  Godfrey Kigozi; Richard Musoke; Stephen Watya; Nehemiah Kighoma; Paschal Ssebbowa; David Serwadda; Fred Nalugoda; Frederick Makumbi; Philip Li; Richard Lee; Marc Goldstein; Maria Wawer; Nelson Sewankambo; Ronald H Gray
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-15       Impact factor: 3.731

2.  Application of a novel disposable suture device in circumcision: a prospective non-randomized controlled study.

Authors:  Zheng Zhang; Baibing Yang; Wen Yu; Youfeng Han; Zhipeng Xu; Hai Chen; Yun Chen; Yutian Dai
Journal:  Int Urol Nephrol       Date:  2016-01-22       Impact factor: 2.370

Review 3.  Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan Africa.

Authors:  Richard G Wamai; Brian J Morris; Stefan A Bailis; David Sokal; Jeffrey D Klausner; Ross Appleton; Nelson Sewankambo; David A Cooper; John Bongaarts; Guy de Bruyn; Alex D Wodak; Joya Banerjee
Journal:  J Int AIDS Soc       Date:  2011-10-20       Impact factor: 5.396

4.  Sexual Satisfaction, Performance, and Partner Response Following Voluntary Medical Male Circumcision in Zambia: The Spear and Shield Project.

Authors:  Robert Zulu; Deborah Jones; Ndashi Chitalu; Ryan Cook; Stephen Weiss
Journal:  Glob Health Sci Pract       Date:  2015-12-17

5.  The safety and acceptance of the PrePex device for non-surgical adult male circumcision in Rakai, Uganda. A non-randomized observational study.

Authors:  Godfrey Kigozi; Richard Musoke; Stephen Watya; Nehemia Kighoma; James Nkale; Mary Nakafeero; Dan Namuguzi; David Serwada; Fred Nalugoda; Nelson Sewankambo; Maria Joan Wawer; Ronald Henry Gray
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

6.  Simplifying the ShangRing technique for circumcision in boys and men: use of the no-flip technique with randomization to removal at 7 days versus spontaneous detachment.

Authors:  Mark A Barone; Philip S Li; Richard K Lee; Daniel Ouma; Millicent Oundo; Mukhaye Barasa; Jairus Oketch; Patrick Otiende; Nixon Nyangweso; Mary Maina; Nicholas Kiswi; Betty Chirchir; Marc Goldstein; Quentin D Awori
Journal:  Asian J Androl       Date:  2019 Jul-Aug       Impact factor: 3.285

7.  Clinical Outcomes And Risk Factors In Patients Circumcised By Chinese Shang Ring: A Prospective Study Based On Age And Types Of Penile Disease.

Authors:  Hui Wang; Zhenyu Huang; Jun Zhou; Xiansheng Zhang; Chaozhao Liang
Journal:  Ther Clin Risk Manag       Date:  2019-10-21       Impact factor: 2.423

Review 8.  Clinical trials using the Shang Ring device for male circumcision in Africa: a review.

Authors:  Mark A Barone; Philip S Li; Quentin D Awori; Richard Lee; Marc Goldstein
Journal:  Transl Androl Urol       Date:  2014-03

9.  Surgical Outcomes of Newly Trained ShangRing Circumcision Providers.

Authors:  Quentin D Awori; Richard K Lee; Philip S Li; Robert Zulu; Kawango Agot; Stephanie Combes; Raymond O Simba; Catherine Hart; Jaim Jou Lai; Zude Zyambo; Marc Goldstein; Paul J Feldblum; Mark A Barone
Journal:  J Acquir Immune Defic Syndr       Date:  2016-06-01       Impact factor: 3.731

10.  Men's Understanding of and Experiences During the Postcircumcision Abstinence Period: Results From a Field Study of ShangRing Circumcision During Routine Clinical Services in Kenya and Zambia.

Authors:  Mark A Barone; Philip S Li; Robert Zulu; Quentin D Awori; Kawango Agot; Stephanie Combes; Raymond O Simba; Richard K Lee; Catherine Hart; Jaim Jou Lai; Zude Zyambo; Marc Goldstein; Paul J Feldblum; David C Sokal
Journal:  J Acquir Immune Defic Syndr       Date:  2016-06-01       Impact factor: 3.731

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.